5 Best Peptide Stacks for Weight Loss and Muscle Gain | Newtropin

Peptide monotherapy can deliver meaningful results, but strategically combining peptides — what practitioners call “stacking” — can dramatically amplify outcomes by targeting multiple pathways simultaneously. The best peptide stacks for weight loss and muscle gain pair compounds that complement rather than duplicate each other’s mechanisms: one peptide stimulates GH release while another suppresses appetite, or one drives fat oxidation while another accelerates tissue repair. Whether you’re a complete beginner or an experienced patient looking to optimize your protocol, these five stacks represent the most clinically supported and real-world-proven combinations available through licensed compounding pharmacies today.

Peptide Stacks Compared

The best peptide stack for muscle growth and fat loss depends on the goal, but none of the five combinations below has been tested as a pair in a published randomized trial: the evidence comes from studies of each component on its own. The table summarizes what each part adds, the evidence level and current regulatory status (see the FDA Peptide Status Tracker).

Stacking decisions, including whether to combine at all, belong to the prescribing clinician; this guide does not cover dosing.

1. CJC-1295 + Ipamorelin — The Classic Recomposition Stack

Best for: General fat loss + lean muscle

This is the most widely prescribed peptide stack in the compounding pharmacy world for good reason. CJC-1295 is a GHRH analogue that extends the duration of growth hormone signaling, while Ipamorelin is a selective GHRP that amplifies the size of GH pulses without triggering cortisol or prolactin elevation. Together, they produce a robust, sustained increase in natural GH output — typically 3–5x above baseline when dosed correctly. The synergy here is straightforward: CJC-1295 opens the GH floodgate, Ipamorelin pushes more GH through it. The combined effect drives lipolysis, supports lean muscle protein synthesis, improves sleep architecture, and enhances recovery. Most patients see measurable body composition changes within 8–12 weeks. See [our CJC-1295 + Ipamorelin guide] for complete dosing and protocol details.

2. BPC-157 + TB-500 — The Recovery and Recomposition Stack

Best for: Injury recovery + recomposition

BPC-157 (Body Protective Compound 157) and TB-500 (Thymosin Beta-4) are two of the most powerful healing peptides available. BPC-157 promotes angiogenesis (new blood vessel formation), accelerates tendon and ligament healing, modulates the gut-brain axis, and has demonstrated remarkable tissue repair properties in both animal and early human research. TB-500 upregulates actin, a protein critical to cell proliferation and migration, and has shown particular effectiveness for muscle and soft tissue injury recovery. Together, they create a comprehensive repair environment: BPC-157 promotes structural healing while TB-500 accelerates cellular regeneration. For patients whose weight gain or muscle loss is partly due to pain and injury limiting their activity, this stack can be transformational — it removes the physical barriers to training.

3. Semaglutide + Tesamorelin — The Aggressive Fat Loss Stack

Best for: Significant fat loss, especially visceral fat

This is arguably the most powerful combination for patients whose primary goal is significant fat loss — particularly visceral adipose tissue reduction. Semaglutide’s GLP-1 receptor agonism delivers potent appetite suppression and slows gastric emptying, creating a large caloric deficit without hunger. Tesamorelin simultaneously works at the pituitary level to stimulate GH release, driving lipolysis preferentially in visceral fat depots — the most metabolically dangerous fat in the body. The synergy: semaglutide reduces caloric intake while Tesamorelin optimizes how the body utilizes stored fat. Clinically, this stack can produce aggressive fat loss outcomes superior to either agent alone. It requires medical supervision, careful titration, and regular monitoring of IGF-1 and metabolic markers. See [our complete peptide weight loss guide] for context on when this stack is appropriate.

4. AOD-9604 + GHRP-6 — The Targeted Fat Mobilization Stack

Best for: Stubborn fat, appetite control

AOD-9604 is a modified HGH fragment (residues 177–191) that directly stimulates lipolysis and inhibits lipogenesis through beta-3 adrenergic receptor activity, without affecting blood glucose or IGF-1 levels. GHRP-6 is a first-generation GHRP that powerfully stimulates GH release and also has a notable appetite-stimulating effect (through ghrelin mimicry) — making it useful for patients who need caloric support for muscle preservation while losing fat. The combination creates a dual-action effect: AOD-9604 mobilizes stored fat for oxidation while the GH surge from GHRP-6 drives lipolysis and muscle protection. GHRP-6’s appetite effect can be managed with careful timing — typically injecting post-workout when increased food intake is beneficial. This stack is particularly useful for leaner patients working on stubborn fat deposits.

5. Sermorelin + Ipamorelin — The Beginner-Friendly Stack

Best for: First-time peptide users, sustainable HGH restoration

For patients new to peptide therapy, Sermorelin + Ipamorelin offers an ideal entry point: effective, well-tolerated, and highly physiological in its mechanism. Sermorelin is a truncated GHRH analogue (the first 29 amino acids of GHRH) with an excellent safety record and decades of clinical use. Ipamorelin adds the GHRP component, enhancing the amplitude of GH pulses without the prolactin and cortisol baggage of older GHRPs like GHRP-2 or GHRP-6. Together, they stimulate natural GH secretion in a pulsatile, regulated fashion — mimicking youthful GH patterns without suppressing the hypothalamic-pituitary axis. This is a sustainable long-term protocol appropriate for adults over 35 experiencing the typical hormonal decline of aging, offering improvements in body composition, sleep, energy, and recovery over a 3–6 month period.

Find the Right Stack for Your Goals

The right peptide stack depends on your specific goals, health history, current hormone levels, and tolerance for complexity. Start by getting your IGF-1 and metabolic markers tested, then work with a qualified peptide therapy provider to design a protocol matched to your biology. Visit newtropin.com to explore [our complete peptide weight loss guide], connect with experienced providers, and discover which stack is right for you. Don’t guess — optimize.

Medical Disclaimer This content is for informational purposes only. Always consult a qualified healthcare provider before starting any peptide or hormone therapy.

Frequently Asked Questions

What is the best peptide stack for muscle growth and fat loss?

There is no trial-proven best stack. The most commonly prescribed recomposition pairing is CJC-1295 with ipamorelin, which combines a GHRH analogue with a ghrelin-receptor agonist to raise GH output, but the pair has not been tested together in published randomized trials. For muscle-specific options, see peptides for muscle growth.

What are the best peptide stacks for weight loss?

For meaningful weight loss, the only agents with large randomized-trial evidence are the GLP-1-class drugs such as semaglutide and tirzepatide, which are FDA-approved. GH-axis peptides and fragments like AOD-9604 have much weaker human evidence for weight loss. Our ranking of the best single peptides for fat loss compares them one by one.

Can you stack peptides?

Clinicians do prescribe peptides in combination, usually pairing compounds with different mechanisms (for example, a GHRH analogue with a ghrelin-receptor agonist). Combining agents multiplies the unknowns, though: interactions, additive side effects and IGF-1 or glucose changes are rarely studied for specific pairs. Any stack should be designed and monitored by a licensed prescriber.

Are peptide stacks safe?

Safety data exist mostly for individual FDA-approved drugs, not for combinations. Pairing GH secretagogues is meant to raise GH and IGF-1 more than either alone, and GH secretagogues have been associated with higher blood glucose and reduced insulin sensitivity; many research peptides have little long-term human safety data. Our weight-loss peptide safety guide covers side effects and monitoring.

Are the peptides in these stacks legal to prescribe?

Semaglutide, tirzepatide and tesamorelin are FDA-approved drugs. BPC-157 and TB-500 received favorable PCAC votes in July 2026, but they are not on the 503A Bulks List until FDA completes rulemaking, expected to run into 2027. Check the FDA Peptide Status Tracker for each compound's current status.

References

1. Teichman SL, et al. Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults. J Clin Endocrinol Metab. 2006;91(3):799-805. PubMed
2. Raun K, et al. Ipamorelin, the first selective growth hormone secretagogue. Eur J Endocrinol. 1998;139(5):552-561. PubMed
3. Bowers CY, et al. On the in vitro and in vivo activity of a new synthetic hexapeptide that acts on the pituitary to specifically release growth hormone. Endocrinology. 1984;114(5):1537-1545. PubMed
4. Gwyer D, et al. Gastric pentadecapeptide body protection compound BPC 157 and its role in accelerating musculoskeletal soft tissue healing. Cell Tissue Res. 2019;377(2):153-159. PubMed
5. Goldstein AL, et al. Thymosin β4: a multi-functional regenerative peptide. Basic properties and clinical applications. Expert Opin Biol Ther. 2012;12(1):37-51. PubMed
6. Wilding JPH, et al. Once-weekly semaglutide in adults with overweight or obesity. N Engl J Med. 2021;384(11):989-1002. PubMed
7. Falutz J, et al. Metabolic effects of a growth hormone-releasing factor in patients with HIV. N Engl J Med. 2007;357(23):2359-2370. PubMed
8. Ng FM, et al. Metabolic studies of a synthetic lipolytic domain (AOD9604) of human growth hormone. Horm Res. 2000;53(6):274-278. PubMed
9. Corpas E, et al. Human growth hormone and human aging. Endocr Rev. 1993;14(1):20-39. PubMed
10. Sigalos JT, Pastuszak AW. The safety and efficacy of growth hormone secretagogues. Sex Med Rev. 2018;6(1):45-53. PubMed